Please assess the completion status of the following clinical trial:

Trial Title: A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* \>= to 18 years of age~* Hypertension uncontrolled on current monotherapy~* Females:~* negative serum pregnancy test at screening~* post menopausal or have had a hysterectomy or tubal ligation or practicing approved methods of birth control~Exclusion Criteria:~* Pregnant females~* Uncontrolled hypertension with multiple drugs, except for hydrochlorothiazide/triamterene~* Diabetes requiring insulin~* Serious disorders that may limit the ability to evaluate the efficacy or safety of treatment~* History of myocardial infarction, bypass graft, angioplasty or heart failure within the past 6 months~* History of Class III or IV congestive heart failure~* History of stroke or transient ischemic attack within the last 1 year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Azor tablets and hydrochlorothiazide tablets (if necessary) will be administered for up to 20 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).